Channels - Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity :: FRELIP Discovery

Similar Items: Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity

Quick Look
Sarcopenia and sarcopenic obesity in type 2 diabetes mellitus and cardiovascular disease: current perspective and narrative review
Quick Look
Comparative Effectiveness of CagriSegma, Semaglutide, Cagrilintide and Tirzepatide in the Management of Overweight and Obesity: A Network Meta‐Analysis of Randomized Clinical Trials
Quick Look
Cystatin C and Its Role in Patients with Type 1 and Type 2 Diabetes Mellitus
Quick Look
Thyroid Diseases in Omani Type 2 Diabetics: A Retrospective Cross-Sectional Study
Quick Look
Mitochondria-targeting compounds for management of metabolic and hemostatic abnormalities associated with heart dysfunctions in experimental type 2 diabetes
Quick Look
Insights from maturity-onset diabetes of the young into impaired insulin secretion in type 2 diabetes
Quick Look
Lipid Peroxidation and Antioxidant Status in Nonobese Type 2 Diabetes Mellitus
Quick Look
Circulating CXCL1 in newly diagnosed type 2 diabetes: context-dependent association with inflammatory load and metabolic indices
Quick Look
Prevalence and predictors of poor glycemic control in patients with type 2 diabetes mellitus attending Alexandria Main University Hospital
Quick Look
The power of lifestyle intervention to induce glycaemic control in a patient with newly diagnosed type 2 diabetes and HbA1c >10%
Quick Look
Predictors of Erectile Dysfunction in Men with Type 2 Diabetes Mellitus Referred to a Tertiary Healthcare Centre
Quick Look
Endogenous intoxication and morpho-functional changes in the liver during experimental acute generalized peritonitis in diabetic rats
Quick Look
The clinical significance of SIGLEC1 mRNA levels derived from peripheral leukocytes in autoimmune thyroid diseases and type 1 diabetes
Quick Look
Lean, Non‐Autoimmune Young‐Onset Diabetes in Bangladesh: A Metabolically Obese Phenotype With Disproportionate Insulin Secretory Defect
Quick Look
Effects of Low-Dose Pioglitazone on Serum Levels of Adiponectin, Dehydroepiandrosterone, Amyloid Beta Peptide, and Lipid Profile in Elderly Japanese People with Type 2 Diabetes
Quick Look
Bone Health in Type 1 Diabetes: Where We Are Now and How We Should Proceed
Quick Look
Pheochromocytoma and primary hyperparathyroidism: a very rare association in a neurofibromatosis type 1 patient unmasked by Takotsubo syndrome
Quick Look
Hypoglycemia Reporting in GLP‐1RA Trials for Type 1 Diabetes: A Critical Gap That Needs To Be Addressed
Quick Look
Efficacy of iodine-131-metaiodobenzylguanidine therapy for multiple endocrine neoplasia type 2A-associated metastatic pheochromocytoma: case report and literature review
Quick Look
ZFP36-ferroptosis axis as a key renal protective pathway in diabetic kidney disease
Quick Look
A silent aggressor: disseminated histoplasmosis with laryngeal and adrenal involvement in a diabetic patient
Quick Look
Oral health-related behaviors and prevalence of thyroid diseases in Iranian patients
Quick Look
Understanding the mechanisms underlying obesity induced tumorigenesis: therapeutic perspectives to manage dysregulated lipid metabolism
Quick Look
Endogenous Glucagon-Like Peptide-1 as a Potential Mediator of the Resolution of Diabetic Kidney Disease following Roux en Y Gastric Bypass: Evidence and Perspectives